In the mouse B16 tumor model, activated S1PR1 can accelerate tumor progression by activating STAT3 and upregulating IL-6 [75], and this relationship between S1PR1 and STAT3 has been shown to contribute to chronic intestinal inflammation and colitis-associated colon cancer [57]. Here, S1PR1 is linked to malignant colon neoplasm.